A little over two years ago, I stood in front of the @LoyolaStritch Class of 2026 as their M2 pathology instructor before heading to Michigan. Last week, I had the profound honor of returning to deliver their commencement address. Full circle in the best possible way. I spoke to them about curiosity, wonder, resilience. About the bone marrow, of course (I promise it made sense). I want them to remember that medicine is still sacred work. In a world moving faster and louder every day, I hope they protect the part of themselves that still pauses in awe at the privilege of caring for another human being. To the Stritch School of Medicine Class of 2026: thank you for allowing me to be a small part of your journey, both then and now. Watching you cross that stage was a privilege I will never forget. Never stop exploring. piped.video/JRSdL1LpDrg?si=IuhG…

Before a breast cancer treatment plan, there’s a diagnosis. And behind that diagnosis is a pathologist. ASCP CEO and breast pathologist, Ali Brown, MD, FASCP, shares the role pathologists play in a breast cancer diagnosis, how their work guides patient care, and why it matters to every patient affected by breast cancer. Your pathologist is part of your care team. Share this video so more patients know. 💗 #BreastCancerAwareness #BreastPathology #Pathology #ASCP

📣 Save the date! HPE Connect ’27 is happening on April 12, 2027, at the Michigan League in Ann Arbor. Join us for a day of connection and collaboration in health professions education! More details coming soon. #HPEConnect27 #GoBlue

As the Chair of the @TheUSCAP Resident Advisory Subcommittee I am so proud of our team for putting together this webinar with Elena Zoniadis, Esq. on navigating legal issues in #pathology reporting Thanks Dr. Maracaja for moderating! uscap.org/lead-well-live-wel…

Happy first day of residency interviews at @umichpath! Wishing every single #PathMatch27 applicant the best of luck! #pathology

How do we eliminate global inequities in digital pathology? 🌍🔬 In our new paper, we advocate moving beyond traditional top-down technology transfer toward reciprocal innovation — establishing a true bidirectional exchange between high-resource and low-resource health systems. 💡 What high-resource settings bring: Regulatory standards, validation frameworks, and subspecialty mentorship. 💡 What low-resource settings teach us: Frugal engineering, resilient hub-and-spoke telepathology models, and cost-efficient workflows. 🎥 Watch our cinematic video abstract to see how collaborative networks and open-source tools can democratize diagnostic access globally! 📄 Read our paper: lnkd.in/gwt9EM5y Arvind Rao, @AkbarWaljee, Priscilla Waithira Njenga, Ulysses G. J. Balis, Mansoor Saleh, Shane Quinonez

🎃 As pathologists and lab professionals, we've seen it all...and it takes a lot to spook us! Share your "scariest" pathology or laboratory horror stories or images — real or imagined! 👻 Biomarkers that go boo? 🔬 Lab equipment coming to life? 💨 Vanishing specimens? 🦠 Petrifying petri cultures? Tell us about the best frights! #ASCPSpookyShares

Don't miss this!!

Hungry for more gastrointestinal pathology knowledge? Dr. Jackie Birkness-Gartman from Johns Hopkins has authored amazing free GI pathology modules for the Open Pathology Education Network. Take a look and see how much there is to learn. open-pathology.org/ #pathology #gipath

A diagnosis can change a life. Access to one should never depend on where that life is lived. Today, I’m honored to deliver the keynote at the Pathologists Overseas 2026 Virtual Gala, celebrating 35 years of service. What I admire about PO is its commitment to the people and systems that make diagnosis possible. Working alongside local laboratory professionals, PO supports education, quality assurance, and laboratory information systems that help turn expertise into reliable answers for patients. Behind every specimen is someone waiting. Behind every timely, accurate diagnosis is a team whose knowledge, resources, and dedication make the next step in care possible. That is work worth celebrating. And it is work worth supporting. Please join us today, recognize the founders and partners who have sustained this mission, and help support its next chapter. Attend, donate, volunteer, or share PO’s work with someone who should know about it. 📅 Today, October 22 | Noon to 2 p.m. Eastern 🎤 My keynote: 12:30 p.m. Eastern 🌍 Virtual, wherever you are Join the celebration and support PO: pathologistsoverseas.org/vir… #PathologistsOverseas #GlobalHealthEquity #Pathology #LaboratoryMedicine

FREE virtual lecture series on core pathology topics, brought to you by @UMichPath Save this website and share #PathX gpalmc.org/lecture-series/ gpalmc.org/schedule/ @Path_SIG @DOResMatch @MatchToPath

Hello, Friends. I'm thrilled to invite you to this month's @ISIMMweb webinar scheduled for Wednesday, October 21, at 11 am ET. @natasharekhtman is discussing updates on IHC applications in lung neuroendocrine tumors--especially timely given the new IASLC classification and forthcoming WHO Blue Book. Register here: isimm.org/diagnostic-prognos…

🏆 Introducing our first-ever Power List Hall of Fame! Celebrating 15 inaugural inductees whose contributions have shaped pathology and laboratory medicine. 👏 Join us in honouring them! 🔬 Meet the inductees: ow.ly/awE750ZYmB7 #Pathology #HallofFame

One of 15 inaugural inductees into The Pathologist’s Hall of Fame - I am stunned 🥹 Look at my fellow honorees. What extraordinary company. ❤️ Recognition is currency. I intend to pay it forward 🙏🏽 thepathologist.com/power-lis…

Plasma cells are amazing! Their appearance reflects an extraordinary commitment to antibody production: the eccentric nucleus, the abundant cytoplasm filled with rough endoplasmic reticulum, the pale Golgi hof. Features we learn early in training become more interesting as we come to understand what they represent. Some plasma cells persist for decades, producing antibodies against infections we have long forgotten. I find that remarkable. Part of our immunologic history is maintained by these cells, quietly at work in the marrow. In neoplasia, they may retain that familiar appearance while producing a protein capable of causing profound injury. A seemingly mature plasma cell can belong to a clone whose antibodies damage the kidneys, deposit in tissues, or increase blood viscosity. Its appearance alone tells us surprisingly little about the harm it can cause. (Images of plasma cell myeloma and rouleaux) #Hematopathology #Pathology #hemepath #mmsm

Dear hematology lovers & trainees We are bringing the hematology quiz & flash cards back to ASH-a-palooza #ASH26 We need 2 volunteers to help us at the #ASHImageBank booth on Friday. Pls let me know if U are interested in joining us. As always, the games will be fun and the competition will be 🔥 🥇

It’s official: the @ASH_hematology Image Bank quiz cards will be back @ #AshAPalooza at #ASH2024 🥳 By popular demand, we’re updating the #ASHImageBank flash cards & will give out to at our booth! Send us Ur favorite images that U think deserve to be included in the deck. U can self nominate. will include malignant and classical.

🏆 A new chapter in Power List history! This Monday, we're launching The Pathologist's FIRST-EVER Hall of Fame! 🌟 Honouring repeat Power List stars with a permanent place in history, while making room for new voices. 👀 Who will be inducted? #PowerList2026 #Pathology

Molecular and Cellular Pathology graduate students have the opportunity to bridge science and business as members of U-M’s miLEAD Consulting. miLEAD connects graduate students and postdocs with real-world consulting projects, helping startups bring innovations to market while building skills beyond the lab. Read about the program: michmed.org/PP25Z @MCP_Grad_Prog